Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA14 - Palliative and Supportive Care - The Forgotten Trade
- 14:30 - 15:30
- 8/09/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Mini Oral
- Track: Palliative and Supportive Care
- Moderators:Maria Werner-Wasik, Satoko Kono
-
+
Session Moderator
14:47 - 14:57 | Presenter: Maria Werner-Wasik
- Abstract
Loading... -
+
Session Moderator
14:47 - 14:57 | Presenter: Satoko Kono
- Abstract
Loading... -
+
MA14.01 - Session Introduction
14:30 - 14:31 | Presenter: Maria Werner-Wasik
- Abstract
Loading... -
+
MA14.02 - Session Introduction
14:31 - 14:32 | Presenter: Satoko Kono
- Abstract
Loading... -
+
MA14.03 - Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC
14:32 - 14:37 | Presenter: Oscar Arrieta
- Abstract
Loading... -
+
MA14.04 - Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study
14:37 - 14:42 | Presenter: Narjust Florez (Duma)
- Abstract
Loading... -
+
MA14.05 - A Double-blind Phase III Trial of Denosumab Biosimilar QL1206 vs Denosumab in Bone Metastatic Tumor: Lung Cancer Cohort Data
14:42 - 14:47 | Presenter: Yan Huang
- Abstract
Loading... -
+
MA14.06 - Discussant
14:47 - 14:57 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
MA14.07 - The Use of Medical Cannabis Concomitantly with Immune-Check Point Inhibitors (ICI) in Non Small Cell Lung Cancer (NSCLC): A Sigh of Relief?
14:57 - 15:02 | Presenter: Barliz Waissengrin
- Abstract
Loading... -
+
MA14.08 - Longitudinal Symptoms and Health Utility Scores (HUS) in Patients Receiving PD-1 Inhibitors for Metastatic NSCLC
15:02 - 15:07 | Presenter: Christopher Poletes
- Abstract
Loading... -
+
MA14.09 - Lower Paraspinous Muscle Index at First Thoracentesis is Associated with Poor Survival in Non-Small Cell Lung Cancer
15:07 - 15:12 | Presenter: Candice L. Wilshire
- Abstract
Loading... -
+
MA14.10 - Discussant
15:12 - 15:22 | Presenter: Devayani Niyogi
- Abstract
Loading... -
+
MA14.11 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
Session Moderator
14:32 - 00:00 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
Session Moderator
14:32 - 00:00 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.01 - Session Introduction
14:30 - 14:31 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
OA15.02 - Session Introduction
14:31 - 14:32 | Presenter: António Araújo
- Abstract
Loading... -
+
OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100
14:32 - 14:42 | Presenter: Martin Reck
- Abstract
Loading... -
+
OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
14:42 - 14:52 | Presenter: Solange Peters
- Abstract
Loading... -
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Presenter: Delvys Rodriguez-Abreu
- Abstract
Loading... -
+
OA15.07 - Discussant
15:12 - 15:22 | Presenter: Puey Ling Chia
- Abstract
Loading... -
+
OA15.08 - Live Q&A
15:22 - 15:30
- Abstract
Loading...
-
+
PL05 - Closing Plenary 5: Access to Drugs (Live Streamed Session)
- 15:45 - 16:45
- 8/09/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Yi-Long Wu, Clarissa Mathias
-
+
Session Moderator
Presenter: Yi-Long Wu- Abstract
Loading... -
+
Session Moderator
Presenter: Clarissa Mathias- Abstract
Loading... -
+
PL05.01 - Session Introduction
Presenter: Yi-Long Wu- Abstract
Loading... -
+
PL05.02 - Session Introduction
Presenter: Clarissa Mathias- Abstract
Loading... -
+
PL05.03 - How to Double Lung Cancer Survival within 5 Years
Presenter: Giorgio Scagliotti- Abstract
Loading... -
+
PL05.04 - Access to Drugs
Presenter: Nir Peled- Abstract
Loading... -
+
PL05.05 - Drug Development in the 21st Century
Presenter: Francesco Pignatti- Abstract
Loading... -
+
PL05.06 - Closing Remarks
- Abstract
Loading...
first
prev